Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

IGC Pharma, Inc. (IGC) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$0.27M
Net Income	$-2.94M
Cost of Goods Sold	$0.22M
Gross Profit	$0.05M
Operating Expenses	$3.05M
Operating Income	$-2.78M
Non-Operating Income/Expense	$-0.15M
Pre-Tax Income	$-2.94M
Normalized Pre-Tax Income	$-2.94M
Income after Taxes	$-2.94M
Income from Continuous Operations	$-2.94M
Consolidated Net Income/Loss	$-2.94M
Normalized Income after Taxes	$-2.94M
EBIT	$-2.78M
EBITDA	$-2.73M
Weighted-Average Shares Outstanding (Basic)	100.33M
Weighted-Average Shares Outstanding (Diluted)	100.33M
Earnings per Share (EPS) (Basic)	$-0.03
Earnings per Share (EPS) (Diluted)	$-0.03
Balance Sheet Financials
Current Assets	$1.26M
Property, Plant, and Equipment	$2.07M
Long-Term Assets	$8.23M
Total Assets	$9.50M
Current Liabilities	$3.21M
Long-Term Debt	$0.15M
Long-Term Liabilities	$0.15M
Total Liabilities	$3.36M
Common Equity	$6.13M
Tangible Shareholders Equity	$0.62M
Shareholders Equity	$6.13M
Common Shares Outstanding	102.42M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.57M
Cash Flow from Investing Activities	$-0.42M
Cash Flow from Financial Activities	$2.44M
Beginning Cash	$0.90M
End Cash	$0.33M
Increase/Decrease in Cash	$-0.57M
Stock-Based Compensation	$1.76M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.39
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.02
Debt to Equity Ratio	0.18
Gross Margin	18.11%
Operating Margin	-1050.57%
EBIT Margin	-1050.57%
EBITDA Margin	--
Pre-Tax Profit Margin	-1107.92%
Profit Margin	-1107.92%
Free Cash Flow	$-2.58M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.03
Inventory Turnover	0.34
Receiveable Turnover	4.73
Days Sales in Receivables	19.02
Return on Equity	-47.88%
Return on Tangible Equity	-469.76%
Return on Assets	-30.92%
Return on Investments	-46.74%
Book Value Per Share	$0.06
Free Cash Flow per Share	$-0.03
Operating Cash Flow per Share	$-0.03

Data from Zacks Investment Research, Inc.